(Q28115088)

3 January 2017

title

Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response (English)

1 reference

3 January 2017

Lei Sun

1

1 reference

3 January 2017

Jingjing Wu

series ordinal

2

1 reference

3 January 2017

Shounan Yi

series ordinal

3

1 reference

3 January 2017

publication date

1 March 2012

1 reference

3 January 2017

published in

Transplant Immunology

1 reference

3 January 2017

volume

26

1 reference

3 January 2017

issue

2-3

1 reference

3 January 2017

page(s)

71–80

1 reference

Regulatory T cells: key controllers of immunologic self-tolerance

3 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Control of T-cell activation by CD4+ CD25+ suppressor T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Regulatory T cell development in the absence of functional Foxp3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

An essential role for Scurfin in CD4+CD25+ T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Thymic regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

The silent treatment: siRNAs as small molecule drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Silence of the transcripts: RNA interference in medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Interfering with disease: a progress report on siRNA-based therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Natural regulatory T cells: mechanisms of suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Role of LAG-3 in regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

MHC class II expression identifies functionally distinct human regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

IPEX and the role of Foxp3 in the development and function of human Tregs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Transient regulatory T-cells: a state attained by all activated human T-cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

FOXP3 controls regulatory T cell function through cooperation with NFAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

FOXP3: not just for regulatory T cells anymore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Moving to tolerance: clinical application of T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Epigenetic control of the foxp3 locus in regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005

Control of regulatory T cell lineage commitment and maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.10.005